Clinical trial

Use of the Impella BTR™ in Patients With Heart Failure: An Early Feasibility Study

NCT05291884

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2022-04-20

PhaseNA

Study timeline

Study start (actual)2022-04-20Date precision: day

Registry last updated2026-01-08

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Heart Failureunresolved

Acute Decompensated Heart Failureunresolved

Interventions

Impella BTRDEVICE

Sponsors & collaborators

Abiomed Inc.lead sponsor

Mapped research locations

BostonMassachusetts, United States2 AtlantaGeorgia, United States1 ClevelandOhio, United States1 HackensackNew Jersey, United States1 EvanstonIllinois, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05291884 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.